EXPRESSION OF RECOMBINANT HUMAN THYROTROPIN RECEPTOR IN MYELOMA CELLS

被引:19
作者
MATSUBA, T
YAMADA, M
SUZUKI, H
KANAI, A
ISOZAKI, O
YOSHIDA, T
TSUSHIMA, T
YASUKAWA, K
机构
[1] TOSOH CORP,TOKYO RES CTR,AYASE,KANAGAWA 252,JAPAN
[2] TOSOH CORP,DIV SCI INSTRUMENTS,CHUO KU,TOKYO 104,JAPAN
[3] TOKYO WOMENS MED COLL,DEPT MED 2,SHINJUKU KU,TOKYO 160,JAPAN
[4] KEIO UNIV,SCH MED,DEPT INTERNAL MED,SHINJUKU KU,TOKYO 160,JAPAN
[5] KYUSHU INST TECHNOL,FAC COMP SCI & SYST ENGN,DEPT BIOCHEM ENGN & SCI,IIZUKA,FUKUOKA 820,JAPAN
关键词
AUTOANTIBODY; CHO CELL; GRAVES DISEASE; MYELOMA CELL; THYROTROPIN RECEPTOR;
D O I
10.1093/oxfordjournals.jbchem.a124901
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Starting with a previously isolated cDNA for human thyrotropin receptor (TSHR), we established a transformed myeloma cell line, SP56, which expresses human TSHR on its cell surface. Binding analysis showed that SP56 bears 1.1 X 10(5) TSHR per cell with a K-d of 2.2 X 10(-10) M. Using the purified cellular membrane, we established a TSH binding inhibition immunoglobulin (TBII) assay for autoantibodies against TSHR, mie compared it with the TBII assay utilizing porcine thyroid membranes expressing porcine TSHR, which has been widely used for TBII assay, by using 96 serum samples from patients with autoimmune thyroid disease and normal individuals, Our TBII assay was more sensitive than the one using porcine TSHR: of 38 sera of patients which were judged negative for autoantibodies to TSHR (TBII value below 10%) by the latter assay, 28 were positive (above 20%) in our assay, By using a perfusion culture system, we obtained as many as 3 X 10(10) SP56 cells, from which 3,450 mg protein of the membrane could be purified; this is sufficient for 15,000 assays. The results indicate that the membrane of the myeloma cell line SP56 is more suitable for use in the TBII assay than the porcine thyroid membrane, in terms of sensitivity to autoantibodies against TSHR in human sera.
引用
收藏
页码:265 / 270
页数:6
相关论文
共 26 条
[1]   CLONING, CHROMOSOMAL ASSIGNMENT, AND REGULATION OF THE RAT THYROTROPIN RECEPTOR - EXPRESSION OF THE GENE IS REGULATED BY THYROTROPIN, AGENTS THAT INCREASE CAMP LEVELS, AND THYROID AUTOANTIBODIES [J].
AKAMIZU, T ;
IKUYAMA, S ;
SAJI, M ;
KOSUGI, S ;
KOZAK, C ;
MCBRIDE, OW ;
KOHN, LD .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1990, 87 (15) :5677-5681
[2]   THE FUNCTIONAL EXPRESSION OF RECOMBINANT HUMAN THYROTROPIN RECEPTORS IN NONTHYROIDAL EUKARYOTIC CELLS PROVIDES EVIDENCE THAT HOMOLOGOUS DESENSITIZATION TO THYROTROPIN STIMULATION REQUIRES A CELL-SPECIFIC FACTOR [J].
CHAZENBALK, GD ;
NAGAYAMA, Y ;
KAUFMAN, KD ;
RAPOPORT, B .
ENDOCRINOLOGY, 1990, 127 (03) :1240-1244
[3]   HIGH-EFFICIENCY TRANSFORMATION OF MAMMALIAN-CELLS BY PLASMID DNA [J].
CHEN, C ;
OKAYAMA, H .
MOLECULAR AND CELLULAR BIOLOGY, 1987, 7 (08) :2745-2752
[4]   BINDING ASSAY FOR THYROTROPIN RECEPTOR AUTOANTIBODIES USING THE RECOMBINANT RECEPTOR PROTEIN [J].
COSTAGLIOLA, S ;
SWILLENS, S ;
NICCOLI, P ;
DUMONT, JE ;
VASSART, G ;
LUDGATE, M .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1992, 75 (06) :1540-1544
[5]   HETEROGENEOUS RESPONSES OF RECOMBINANT HUMAN THYROTROPIN RECEPTOR TO IMMUNOGLOBULINS FROM PATIENTS WITH GRAVES-DISEASE [J].
ENDO, T ;
OHMORI, M ;
IKEDA, M ;
ANZAI, E ;
ONAYA, T .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1992, 186 (03) :1391-1396
[6]   RECOMBINANT HUMAN THYROTROPIN (TSH) RECEPTOR IN A RADIORECEPTOR ASSAY FOR THE MEASUREMENT OF TSH RECEPTOR AUTOANTIBODIES [J].
FILETTI, S ;
FOTI, D ;
COSTANTE, G ;
RAPOPORT, B .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1991, 72 (05) :1096-1101
[7]   INTERACTION OF THYROTROPIN AND THYROID-STIMULATING ANTIBODIES WITH RECOMBINANT EXTRACELLULAR REGION OF HUMAN TSH RECEPTOR [J].
HARFST, E ;
JOHNSTONE, AP ;
NUSSEY, SS .
LANCET, 1992, 339 (8786) :193-194
[8]   ACUTE EFFECT OF THYROTROPIN ON PHOSPHATIDYLINOSITOL DEGRADATION AND TRANSIENT ACCUMULATION OF DIACYLGLYCEROL IN ISOLATED THYROID-FOLLICLES [J].
IGARASHI, Y ;
KONDO, Y .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1980, 97 (02) :759-765
[9]   AUTOCRINE GROWTH AND TUMORIGENICITY OF INTERLEUKIN-2-DEPENDENT HELPER T-CELLS TRANSFECTED WITH IL-2 GENE [J].
KARASUYAMA, H ;
TOHYAMA, N ;
TADA, T .
JOURNAL OF EXPERIMENTAL MEDICINE, 1989, 169 (01) :13-25
[10]   ESTABLISHMENT OF MOUSE-CELL LINES WHICH CONSTITUTIVELY SECRETE LARGE QUANTITIES OF INTERLEUKIN-2, INTERLEUKIN-3, INTERLEUKIN-4 OR INTERLEUKIN-5, USING MODIFIED CDNA EXPRESSION VECTORS [J].
KARASUYAMA, H ;
MELCHERS, F .
EUROPEAN JOURNAL OF IMMUNOLOGY, 1988, 18 (01) :97-104